Jury Finds in Favor of Takeda in Actos Lawsuit, Turning Down Plaintiff’s Claim

Takeda Pharmaceutical announced on May 16 that the company and its wholly-owned US subsidiary Takeda Pharmaceuticals U.S.A., have received a favorable jury verdict in its type 2 diabetes treatment Actos (pioglitazone) trial. In the trial, the family of a male...read more